Award
Delivery Order #SPE2DR26FJHB1
Short-Term Delivery Order for Glycopyrrolate Vials to Federal Health Program
Buyer
Defense Logistics Agency
Award Amount
$596.28
Ceiling
$596.28
Awarded
February 11, 2026
Period of Performance
Feb 11, 2026 – Feb 12, 2026
Identifier
SPE2DR26FJHB1
NAICS
424210
This award represents a short-term delivery order contract issued under an existing indefinite delivery vehicle (IDV) held by DMS Pharmaceutical Group Inc. The parent IDV supports pharmaceutical services for federal health programs, with a focus on supplying critical medications. DMS Pharmaceutical Group, known for its pharmaceutical distribution capabilities, secured this delivery order to provide Glycopyrrolate 0.2 mg/mL vials in a 20 mL volume. This medication is essential for clinical use within federal healthcare operations, reflecting the contract's importance in maintaining ready access to vital pharmaceuticals. The contract performance is brief, spanning a one-day period, indicating a specific, immediate requirement fulfillment. This award supplements an ongoing support agreement with a multi-year horizon, ensuring continued pharmaceutical support. The contract was awarded through the existing parent contract vehicle, underscoring streamlined procurement to meet urgent needs without separate competitive bidding.
Description
4570846132!GLYCOPYRROLATE 0.2 MG/ML VIAL 20ML